| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 146.409.493 $ | 98,71 | 882.510 | ||||||
| Eli Lilly & Co. | Eli Lilly & Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 20.150.424 $ | 13,59 | 16.800 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 13.468.537 $ | 9,08 | 53.032 | |
| UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 10.698.316 $ | 7,21 | 25.740 | |
| AbbVie, Inc. | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 9.839.124 $ | 6,63 | 39.100 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 8.178.511 $ | 5,51 | 63.646 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 7.530.794 $ | 5,08 | 48.184 | |
| AstraZeneca plc | AstraZeneca plc | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 6.633.978 $ | 4,47 | 35.532 | |
| Intuitive Surgical, Inc. | Intuitive Surgical, Inc. | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 5.313.005 $ | 3,58 | 13.360 | |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 4.933.382 $ | 3,33 | 9.840 | |
| CVS Health Corp. | CVS Health Corp. | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 4.386.280 $ | 2,96 | 42.400 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 4.270.292 $ | 2,88 | 33.800 | |
| Edwards Lifesciences Corp. | Edwards Lifesciences Corp. | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 4.143.068 $ | 2,79 | 45.800 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 3.854.625 $ | 2,60 | 7.760 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Modellwert (Stufe 2) | 3.835.436 $ | 2,59 | 9.330 | |
| Cardinal Health, Inc. | Cardinal Health, Inc. | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 3.587.156 $ | 2,42 | 15.100 | |
| GSK plc | GSK plc | EC | GB00BN7SWP63 | Long | Modellwert (Stufe 2) | 3.373.445 $ | 2,27 | 128.498 | |
| McKesson Corp. | McKesson Corp. | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 3.067.736 $ | 2,07 | 4.060 | |
| Elevance Health, Inc. | Elevance Health, Inc. | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 2.923.679 $ | 1,97 | 7.560 | |
| Waters Corp. | Waters Corp. | EC | 941848103 | Long | Börsenkurs (Stufe 1) | 2.130.227 $ | 1,44 | 5.680 | |
| Dexcom, Inc. | Dexcom, Inc. | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 2.074.380 $ | 1,40 | 30.800 | |
| Novo Nordisk A/S | Novo Nordisk A/S, Class B | EC | DK0062498333 | Long | Modellwert (Stufe 2) | 2.036.343 $ | 1,37 | 42.400 | |
| Hoya Corp. | Hoya Corp. | EC | JP3837800006 | Long | Modellwert (Stufe 2) | 2.032.397 $ | 1,37 | 12.600 | |
| Sanofi SA | Sanofi SA | EC | FR0000120578 | Long | Modellwert (Stufe 2) | 1.700.069 $ | 1,15 | 19.883 | |
| Amgen, Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 1.651.267 $ | 1,11 | 4.560 | |
| Argenx SE | Argenx SE | EC | NL0010832176 | Long | Modellwert (Stufe 2) | 1.446.835 $ | 0,98 | 1.561 | |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 1.411.690 $ | 0,95 | 24.500 | |
| Royalty Pharma plc | Royalty Pharma plc, Class A | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 1.199.898 $ | 0,81 | 21.400 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 1.128.205 $ | 0,76 | 8.500 | |
| Chugai Pharmaceutical Co. Ltd. | Chugai Pharmaceutical Co. Ltd. | EC | JP3519400000 | Long | Modellwert (Stufe 2) | 1.094.779 $ | 0,74 | 23.700 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 916.932 $ | 0,62 | 8.600 | |
| Ligand Pharmaceuticals, Inc. | Ligand Pharmaceuticals, Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 853.443 $ | 0,58 | 2.700 | |
| PACS Group, Inc. | PACS Group, Inc. | EC | 69380Q107 | Long | Börsenkurs (Stufe 1) | 852.800 $ | 0,57 | 20.000 | |
| Celcuity, Inc. | Celcuity, Inc. | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 836.960 $ | 0,56 | 8.000 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 823.582 $ | 0,56 | 1.520 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 821.622 $ | 0,55 | 7.400 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 817.230 $ | 0,55 | 3.064 | |
| Xenon Pharmaceuticals, Inc. | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 784.680 $ | 0,53 | 13.000 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 772.254 $ | 0,52 | 6.300 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 442.988 $ | 0,30 | 5.200 | |
| Newamsterdam Pharma Co. NV | Newamsterdam Pharma Co. NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 393.124 $ | 0,27 | 11.600 | |
| Gesamt | 146.409.493 $ | 98,71 | 882.510 |